CN104435350A - Drug for treating functional uterine bleeding - Google Patents

Drug for treating functional uterine bleeding Download PDF

Info

Publication number
CN104435350A
CN104435350A CN201410642919.0A CN201410642919A CN104435350A CN 104435350 A CN104435350 A CN 104435350A CN 201410642919 A CN201410642919 A CN 201410642919A CN 104435350 A CN104435350 A CN 104435350A
Authority
CN
China
Prior art keywords
parts
radix
herba
paeoniae alba
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410642919.0A
Other languages
Chinese (zh)
Inventor
李�杰
吴润秀
张爱萍
黄结云
黄志超
曾令城
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410642919.0A priority Critical patent/CN104435350A/en
Publication of CN104435350A publication Critical patent/CN104435350A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533—Leonurus (motherwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638—Ligustrum, e.g. Chinese privet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)

Abstract

The invention provides a drug for treating functional uterine bleeding. The drug is characterized by comprising the following components in parts by weight: 10-12 parts of semen cuscutae, 10-12 parts of eclipta, 10-12 parts of teucrium viscidum, 10-12 parts of glossy privet fruit, 10-12 parts of astragalus membranaceus, 10-12 parts of hairyvein agrimony, 10-12 parts of radix paeoniae alba, 10-12 parts of radix rehmanniae preparata, 10-12 parts of bighead atractylodes rhizome, 10-12 parts of wolfberry, 10-12 parts of dried radix rehmanniae, 10-12 parts of radix paeoniae alba, 10-12 parts of angelica, 10-12 parts of ligusticum wallichii, 10-12 parts of safflower, 10-12 parts of motherwort and 10-12 parts of licorice. The drug has the advantages of easiness for obtaining raw materials, low cost and significant treatment effect.

Description

Treatment dysfunctional uterine hemorrhage medicine
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicinal formulae.
Background technology
Chinese medicine (Chinese herbology, Traditional Materia Medica), refers to the medicine of application under Han nationality's folk medicine instructs.Chinese medicine is divided into Chinese patent medicine, Chinese crude drug by processing technique.Chinese medicine is originating primarily from China, except plant amedica, animal drugs as Fel Serpentis, Fel Ursi, Agkistrodon, Cornu Cervi Pantotrichum, Cornu Cervi etc.; Shell class as Margarita, Concha Meretricis seu Cyclinae; Mineral substance is as Os Draconis, and Magnetitum etc. are all used to the Chinese medicine of curing the disease.Minority Chinese medicine comes from foreign country, as Radix Panacis Quinquefolii.China working people, for thousands of years in the process combated the disease, by practice, is constantly familiar with, have accumulated abundant medicinal knowledge gradually.Because word in period in romote antiquity is not emerging, these knowledge can only rely on transmission from master to disciple oral instruction, have had word afterwards, and have just recorded gradually, and occurred medical book.These books serve sums up forefathers' experience and is convenient to the effect spreading and promote.Chinese medicine has the history of thousands of years, and be that the very rich experience that Chinese people struggle with disease is for a long time summed up, the prosperity for the Chinese nation has huge contribution.Because medicine medium-height grass class is in the great majority, so the books recording medicine are just called " book on Chinese herbal medicine ".According to textual criticism, when Qin Han, book on Chinese herbal medicine is popular more, but these books on Chinese herbal medicine are lost all unfortunately, can not investigate.The herbal the earliest works now known is called Shennong's Herbal, pandect is totally three volumes, record medicine comprise dynamic, plant, ore deposit three class, totally 365 kinds, every medicine item is downloaded to be had nature and flavor, function and cures mainly, and another example in order describes the basic theories of medication briefly, as toxicity or no toxicity, four natures and five flavors of drug, compatibility law, method of administration and ball, fall apart, the dosage form such as cream, wine, can say it is the summary of China's knowledge of medication before the Chinese, and lay a good foundation for later pharmaceutical development.Greatest works in China's book on Chinese herbal medicine history, achievement extremely brilliant in the history of science of Ye Shi China.Now affecting larger is " Dictionary of Chinese Pharmacy " that nineteen thirty-five Chen Cunren writes.Pandect 2,700,000 word, receive 4300, medicine order, every medicine is introduced name, ancient books another name, basic, the place of production, form, character, composition, usefulness respectively, cured mainly, successive dynasties description textual criticism, discrimination, person of modern times's theory, fit applications, consumption, use compatibility and incompatibility of drugs, reference material etc. 21.Abundant information, comprehensively, summarize relevant discussion at all times, and drawings attached.It is first large-scale dictionary on Traditional Chinese Medicine Phylogeny.Maybe about 7,000 hundred million will be reached to Chinese herbal medicine industry total industrial output value in 2015.
Through general retrieval, do not find the scheme identical with present patent application.
Summary of the invention
The object of the invention is to: propose one and treat dysfunctional uterine hemorrhage medicine.
Treatment dysfunctional uterine hemorrhage medicine of the present invention, it is characterized in that: by weight, by Semen Cuscutae 10-12 parts, ink Herba Ecliptae 10-12 parts, Herba Chenopodii Hybridi 10-12 parts, Fructus Ligustri Lucidi 10-12 parts, the Radix Astragali 10-12 parts, Herba Agrimoniae 10-12 parts, the Radix Paeoniae Alba 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae 10-12 parts, Fructus Lycii 10-12 parts, 10-12 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Rhizoma Chuanxiong 10-12 parts, 10-12 parts, Flos Carthami, Herba Leonuri 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition.
Treatment dysfunctional uterine hemorrhage medicine of the present invention, it is characterized in that: by weight, by Semen Cuscutae 10-12 parts, ink Herba Ecliptae 10-12 parts, Herba Chenopodii Hybridi 10-12 parts, Fructus Ligustri Lucidi 10-12 parts, the Radix Astragali 10-12 parts, Herba Agrimoniae 10-12 parts, the Radix Paeoniae Alba 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae 10-12 parts, Fructus Lycii 10-12 parts, 10-12 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Rhizoma Chuanxiong 10-12 parts, 10-12 parts, Flos Carthami, Herba Leonuri 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Pulverize, packaging, obtains product.
Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.
Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, point 3 decoction being taken warmly, every day 1 dose.
Treatment dysfunctional uterine hemorrhage medicine of the present invention, it is characterized in that: by weight, by Semen Cuscutae 10-12 parts, ink Herba Ecliptae 10-12 parts, Herba Chenopodii Hybridi 10-12 parts, Fructus Ligustri Lucidi 10-12 parts, the Radix Astragali 10-12 parts, Herba Agrimoniae 10-12 parts, the Radix Paeoniae Alba 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae 10-12 parts, Fructus Lycii 10-12 parts, 10-12 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Rhizoma Chuanxiong 10-12 parts, 10-12 parts, Flos Carthami, Herba Leonuri 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Adopt the method for prior art to extract active ingredient, make powdered granule product.
Treatment dysfunctional uterine hemorrhage medicine of the present invention, it is characterized in that: by weight, by Semen Cuscutae 10-12 parts, ink Herba Ecliptae 10-12 parts, Herba Chenopodii Hybridi 10-12 parts, Fructus Ligustri Lucidi 10-12 parts, the Radix Astragali 10-12 parts, Herba Agrimoniae 10-12 parts, the Radix Paeoniae Alba 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae 10-12 parts, Fructus Lycii 10-12 parts, 10-12 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Rhizoma Chuanxiong 10-12 parts, 10-12 parts, Flos Carthami, Herba Leonuri 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.
The present invention has the following advantages and effect: the advantages such as it has raw material and is easy to get, and cost is low, and therapeutic effect is remarkable.
Detailed description of the invention
Below in conjunction with test and clinical trial situation, technical scheme of the present invention is described in further detail.
Treatment dysfunctional uterine hemorrhage medicine of the present invention, it is characterized in that: by weight, by Semen Cuscutae 10-12 parts, ink Herba Ecliptae 10-12 parts, Herba Chenopodii Hybridi 10-12 parts, Fructus Ligustri Lucidi 10-12 parts, the Radix Astragali 10-12 parts, Herba Agrimoniae 10-12 parts, the Radix Paeoniae Alba 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae 10-12 parts, Fructus Lycii 10-12 parts, 10-12 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Rhizoma Chuanxiong 10-12 parts, 10-12 parts, Flos Carthami, Herba Leonuri 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Pulverize, packaging, obtains product.
Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.
Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, point 3 decoction being taken warmly, every day 1 dose.
Chinese medicinal formulae of the present invention is proved recipe handed down from one's ancestors, in the past few decades, has treated many patients, has now enumerated model case as follows:
Model case clinical effectiveness:
Lu, female, 31 years old.Go to a doctor because of lasting vaginal hemorrhage 60 days, previously the eumenorrhea, nearly half a year preceeded menorrhea, 10 ~ 20 days a line.This time vaginal hemorrhage 2 days, amount is many, unclean so far, has used toilet paper 3 kilograms, has once taken 6-aminocaprolc acid, vitamin K is invalid.Gynecologial examination: pudendum, vagina have blood, and cervix uteri is smooth, palace body is slightly large, matter is soft, and bilateral adnexa is without exception.Dark tongue quality, yellow and thin fur.Routine blood test: hemoglobin 88%, leukocyte 4800/mm 3, platelet 180,000/mm 3.Diagnosis: dysfunctional uterine hemorrhage (blood-heat type), secondary anemia.Take treatment dysfunctional uterine hemorrhage medicine of the present invention 1 day, blood after 1 dose of taking medicine obviously reduces, and after 5 days, blood only.Continue to take treatment dysfunctional uterine hemorrhage medicine of the present invention 21 days, recovery from illness.
Lee, female, 28 years old.Go to a doctor because of lasting vaginal hemorrhage 12 days, gynecologial examination is diagnosed: pelvic inflammatory disease renvoi vaginal hemorrhage.Take treatment dysfunctional uterine hemorrhage medicine of the present invention 1 day, blood after 2 doses of taking medicine obviously reduces, and after 3 days, blood only.Continue to take treatment dysfunctional uterine hemorrhage medicine of the present invention 12 days, recovery from illness.
5 certain, female, 23 years old.Hemorrhage after dilatation and curettage of uterine, go to a doctor because of lasting vaginal hemorrhage 5 days, take treatment dysfunctional uterine hemorrhage medicine of the present invention 1 day, blood after 2 doses of taking medicine obviously reduces, and after 2 days, blood only.Continue to take treatment dysfunctional uterine hemorrhage medicine of the present invention 5 days, recovery from illness.

Claims (4)

1. a treatment dysfunctional uterine hemorrhage medicine, it is characterized in that: by weight, by Semen Cuscutae 10-12 parts, black Herba Ecliptae 10-12 parts, Herba Chenopodii Hybridi 10-12 parts, Fructus Ligustri Lucidi 10-12 parts, the Radix Astragali 10-12 parts, Herba Agrimoniae 10-12 parts, the Radix Paeoniae Alba 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae 10-12 parts, Fructus Lycii 10-12 parts, 10-12 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Rhizoma Chuanxiong 10-12 parts, 10-12 parts, Flos Carthami, Herba Leonuri 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition.
2. a treatment dysfunctional uterine hemorrhage medicine, it is characterized in that: by weight, by Semen Cuscutae 10-12 parts, black Herba Ecliptae 10-12 parts, Herba Chenopodii Hybridi 10-12 parts, Fructus Ligustri Lucidi 10-12 parts, the Radix Astragali 10-12 parts, Herba Agrimoniae 10-12 parts, the Radix Paeoniae Alba 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae 10-12 parts, Fructus Lycii 10-12 parts, 10-12 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Rhizoma Chuanxiong 10-12 parts, 10-12 parts, Flos Carthami, Herba Leonuri 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Pulverize, packaging, obtains product.
3. a treatment dysfunctional uterine hemorrhage medicine, it is characterized in that: by weight, by Semen Cuscutae 10-12 parts, black Herba Ecliptae 10-12 parts, Herba Chenopodii Hybridi 10-12 parts, Fructus Ligustri Lucidi 10-12 parts, the Radix Astragali 10-12 parts, Herba Agrimoniae 10-12 parts, the Radix Paeoniae Alba 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae 10-12 parts, Fructus Lycii 10-12 parts, 10-12 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Rhizoma Chuanxiong 10-12 parts, 10-12 parts, Flos Carthami, Herba Leonuri 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Adopt the method for prior art to extract active ingredient, make powdered granule product.
4. a treatment dysfunctional uterine hemorrhage medicine, it is characterized in that: by weight, by Semen Cuscutae 10-12 parts, black Herba Ecliptae 10-12 parts, Herba Chenopodii Hybridi 10-12 parts, Fructus Ligustri Lucidi 10-12 parts, the Radix Astragali 10-12 parts, Herba Agrimoniae 10-12 parts, the Radix Paeoniae Alba 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae 10-12 parts, Fructus Lycii 10-12 parts, 10-12 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Rhizoma Chuanxiong 10-12 parts, 10-12 parts, Flos Carthami, Herba Leonuri 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.
CN201410642919.0A 2014-11-13 2014-11-13 Drug for treating functional uterine bleeding Pending CN104435350A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410642919.0A CN104435350A (en) 2014-11-13 2014-11-13 Drug for treating functional uterine bleeding

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410642919.0A CN104435350A (en) 2014-11-13 2014-11-13 Drug for treating functional uterine bleeding

Publications (1)

Publication Number Publication Date
CN104435350A true CN104435350A (en) 2015-03-25

Family

ID=52882611

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410642919.0A Pending CN104435350A (en) 2014-11-13 2014-11-13 Drug for treating functional uterine bleeding

Country Status (1)

Country Link
CN (1) CN104435350A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105250486A (en) * 2015-10-10 2016-01-20 汕头大学医学院第一附属医院 Traditional Chinese medicine for treating postpartum abdominal pain due to blood stasis and metrorrhagia complicaitons

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103330809A (en) * 2013-07-23 2013-10-02 黄淑娟 Traditional Chinese medicine composition for curing functional uterine bleeding

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103330809A (en) * 2013-07-23 2013-10-02 黄淑娟 Traditional Chinese medicine composition for curing functional uterine bleeding

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
轩宇鹏 主编: "《新编中医验方大全》", 31 May 2010 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105250486A (en) * 2015-10-10 2016-01-20 汕头大学医学院第一附属医院 Traditional Chinese medicine for treating postpartum abdominal pain due to blood stasis and metrorrhagia complicaitons

Similar Documents

Publication Publication Date Title
CN102772745B (en) Chinese medicinal preparation for treating cancer and preparation method thereof
CN101653590B (en) Medicine for treating habitual abortion and preparation method thereof
CN104491801A (en) Traditional Chinese medicine preparation for treating acute or chronic gastritis and preparation method thereof
CN102488879A (en) Medicinal composition for treating rheumatism
CN104435424A (en) Medicine for treating male climacteric syndrome
CN104435252A (en) Medicine for treating acute mastitis
CN103356968A (en) Traditional Chinese medicine composition for treating endometriosis
CN104383486A (en) Medicament for treating bronchitis of children
CN104435567A (en) Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout
CN104367888A (en) Medicine for treating acute and chronic balanitis
CN104367949A (en) Medicament for treating urinary calculus
CN104435350A (en) Drug for treating functional uterine bleeding
CN104383485A (en) Medicine for treating infantile anorexia
CN104367951A (en) Medicine for treating prostate hyperplasia
CN1240415C (en) Tablets against allergic purpura
CN101623488A (en) Chinese medicinal composition for treating panasthenia
CN104383046A (en) Medicament for treating infantile diarrhea
CN104367730A (en) Medicine for treating postpartum urinary retention
CN104435313A (en) Medicine for treating haemorrhoids
CN104436029A (en) Drug for treating pelvic inflammatory disease
CN104383223A (en) Medicine for treating chicken pox in children
CN104367777A (en) Medicine for treating spermatorrhea
CN101934047A (en) Chinese medicinal preparation for treating habitual abortion
CN104510941A (en) Medicine for treating chronic nephritis
CN104474377A (en) Medicine for treating rheumatoid arthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150325

WD01 Invention patent application deemed withdrawn after publication